|
|
Prepublished online as a Blood First Edition Paper on August 15, 2002; DOI 10.1182/blood-2002-03-0894.
Previous Article | Table of Contents | Next Article 
Blood, 1 January 2003, Vol. 101, No. 1, pp. 292-294
NEOPLASIA
Brief report
Monoglycerides induce apoptosis in human leukemic cells while
sparing normal peripheral blood mononuclear cells
Fabianne Philippoussis,
Chantal Arguin,
Véronique Mateo,
Ann-Muriel Steff, and
Patrice Hugo
From PROCREA BioSciences, Division of Research and
Development; Department of Microbiology and Immunology, McGill
University; and Laboratoire d'Allergie, Centre de Recherche du Centre
Hospitalier de l'Université de Montréal, Hôpital
Notre-Dame, Université de Montréal; all of Montréal,
QC, Canada.
A major drawback of the current antineoplastic treatments
is their lack of specificity toward cancer cells, because they are most
often cytotoxic to normal cells, thus creating related side effects.
Hence, the identification of new apoptosis-inducing agents, specifically targeting malignant cells while sparing their normal counterparts, is of crucial interest. We show here that
monoglycerides, a family of lipids consisting of a single fatty
acid attached to a glycerol backbone, induce cell death in several
human leukemic cell lines. Importantly, treatment of primary
leukemic cells, obtained from B-cell chronic lymphocytic
leukemia patients, resulted in rapid apoptosis. In striking contrast,
resting or activated human peripheral blood mononuclear cells from
healthy individuals were resistant to the same treatment. Therefore,
these compounds could represent potential antileukemic drugs or could
allow for the design of novel therapeutic agents applied to leukemia.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. T. Jones, E. Addison, J. M. North, M. W. Lowdell, A. V. Hoffbrand, A. B. Mehta, K. Ganeshaguru, N. I. Folarin, and R. G. Wickremasinghe
Geldanamycin and herbimycin A induce apoptotic killing of B chronic lymphocytic leukemia cells and augment the cells' sensitivity to cytotoxic drugs
Blood,
March 1, 2004;
103(5):
1855 - 1861.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|